Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies.
(Q54005683)
scientific article published in May 2001
scientific article published in May 2001
Language:
Current Data About
Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies.
other details
description | scientific article published in May 2001 |
External Links
(P356) |
10.1097/00002371-200105000-00011
|
(P698) |
11394505
|